Immune checkpoint inhibitors combined with chemotherapy/antiangiogenic
therapy for heavily treated advanced lung cancer patients with EGFR
mutation: a retrospective analysis
- Ran Hu,
- Zhiting Zhao,
- Yue Shi,
- Meiqi Shi,
- Guohao Xia,
- Shaorong Yu,
- Jifeng Feng